Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma von Han, Seunggu J, Rolston, John D, Molinaro, Annette M, Clarke, Jennifer L, Prados, Michael D, Chang, Susan M, Berger, Mitchel S, DeSilva, Ashley, Butowski, Nicholas A

Volltext

P17.38 THE EFFECT OF TIMING OF RADIOTHERAPY (RT) IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) RECEIVING TEMOZOLOMIDE (TMZ): AN ANALYSIS BASED ON THE UCSF EXPERIEN... von Han, S. J., Rutledge, W. C., Molinaro, A. M., Chang, S., Clarke, J. L., Prados, M. D., Berger, M. S., Butowski, N. A.

Volltext

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02) von Iwamoto, Fabio M., Lamborn, Kathleen R., Robins, H. Ian, Mehta, Minesh P., Chang, Susan M., Butowski, Nicholas A., DeAngelis, Lisa M., Abrey, Lauren E., Zhang, Wei-Ting, Prados, Michael D., Fine, Howard A.

Volltext

A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma von Clarke, Jennifer L, Molinaro, Annette M, Phillips, Joanna J, Butowski, Nicholas A, Chang, Susan M, Perry, Arie, Costello, Joseph F, DeSilva, Ashley A, Rabbitt, Jane E, Prados, Michael D

Volltext

P08.01 Impact of cannabis use on quality of life in patients with central nervous system tumors von Rodriguez Almaraz, J E, Butowski, N A, Chang, S M, Oberheim-Bush, N A E, Clarke, J R, Taylor, J W, Buerki, R A, Berger, M S

Volltext

Diagnosis and Treatment of Recurrent High-Grade Astrocytoma von Butowski, Nicholas A, Sneed, Patricia K, Chang, Susan M

Volltext

Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma von Essock-Burns, Emma, Lupo, Janine M., Cha, Soonmee, Polley, Mei-Yin, Butowski, Nicholas A., Chang, Susan M., Nelson, Sarah J.

Volltext

IL-1 IDHWT GLIOBLASTOMA LONGITUDINAL MOLECULAR EVOLUTION von Lucas, C G, Al-Adli, N, Young, J S, Gupta, R, Morshed, R A, Wu, J, Ravindranthan, A, Shai, A, Oberheim Bush, N A, Taylor, J W, de Groot, J, Villanueva-Meyer, J E, Pekmezci, M, Perry, A, Bolen, A W, Theodosopoulos, P V, Aghi, M K, Chang, E F, Hervey-Jumper, S L, Raleigh, D R, Molinaro, A M, Costello, J, Diaz, A A, Clarke, J L, Butowski, N A, Phillips, J J, Chang, S M, Berger, M S, Solomon, D A

Volltext

OS11.5 ACT IV: An international, double-blind, phase 3 trial of rindopepimut in newly diagnosed, EGFRvIII-expressing glioblastoma von Weller, M., Butowski, N. A., Tran, D. D., Recht, L. D., O’Rourke, D. M., Finocchiaro, G., Perry, J. R., Wick, W., Stupp, R., Sampson, J. H.

Volltext

P09.59 Phase 2 trial of palbociclib in adult patients with recurrent Rb positive glioblastoma von Taylor, J. W., Molinaro, A. M., Phillips, J. J., James, C. D., Butowski, N. A., Clarke, J. L., Oberheim Bush, N., Chang, S. M., Berger, M. S., Prados, M.

Volltext

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme von Khayal, Inas S., Polley, Mei-Yin C., Jalbert, Llewellyn, Elkhaled, Adam, Chang, Susan M., Cha, Soonmee, Butowski, Nicholas A., Nelson, Sarah J.

Volltext

Assessment of diffusion parameters in scans prior to progression in GBM patients following antiangiogenic therapy von Jalilian, L., Essock-Burns, E., Cha, S., Chang, S. M., Butowski, N. A., Nelson, S. J.

Volltext

Autologous heat shock protein vaccine (HSPPC-96) for patients with recurrent glioblastoma (GBM): Results of a phase II multicenter clinical trial with immunological assessments von Parsa, A., Crane, C., Han, S., Kivett, V., Fedoroff, A., Butowski, N. A., Chang, S. M., Clarke, J. L., Berger, M. S., McDermott, M., Aghi, M., Yanes, C., Prados, M., Sloan, A. E., Bruce, J. N.

Volltext

Phase II and pharmacogenomics study of enzastaurin plus temozolomide and radiation in patients with GBM von Butowski, N. A., Lamborn, K., Polley, M. C., Clarke, J. L., Nicole, A., Page, M., Nicol, S., Thornton, D., Chang, S. M., Prados, M.

Volltext

Phase II and pharmacogenomics study of enzastaurin plus temozolomide and radiation therapy in patients with glioblastoma multiforme or gliosarcoma von Butowski, N. A., Lamborn, K., Chang, S., Hsieh, E., Fedoroff, A., Parvataneni, R., Nicol, S., Liepa, A., Thornton, D., Prados, M.

Volltext

Phase I/II study of enzastaurin (ENZ) plus temozolomide (TMZ) and radiation therapy (XRT) in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS) von Butowski, N. A., Lamborn, K., Chang, S., Page, M., Rabbitt, J., Fedoroff, A., Parvataneni, R., Nicol, S. J., Thornton, D., Prados, M. D.

Volltext

Phase I/II study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme (GBM) or gliosarcoma von Butowski, N. A., Lamborn, K., Chang, S., Thornton, D., DeBoer, R., Page, M., Rabbitt, J., Parvanateni, R., Kivett, V., Nicol, S., Prados, M.

Volltext

Addition of plant dietary fibre to a raw red meat high protein, high fat diet, alters the faecal bacteriome and organic acid profiles of the domestic cat (Felis catus) von Butowski, Christina F, Thomas, David G, Young, Wayne, Cave, Nick J, McKenzie, Catherine M, Rosendale, Douglas I, Bermingham, Emma N

Volltext

Geneza moralności w świetle etyki ewolucyjnej von Butowski, Krzysztof

Volltext

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial von Bloch, Orin, Crane, Courtney A, Fuks, Yelena, Kaur, Rajwant, Aghi, Manish K, Berger, Mitchel S, Butowski, Nicholas A, Chang, Susan M, Clarke, Jennifer L, McDermott, Michael W, Prados, Michael D, Sloan, Andrew E, Bruce, Jeffrey N, Parsa, Andrew T

Volltext